Newsroom

COURBEVOIE, France--(BUSINESS WIRE)--Bureau Veritas (BOURSE:BVI): L’exécution de LEAP | 28 a transformé Bureau Veritas en une société multi-spécialiste plus recentrée, plus performante et à plus forte croissance. Son modèle opérationnel axé sur les Lignes de Produits associe l’échelle mondiale de la Société et sa résilience à des priorités claires, une responsabilisation accrue et une expertise spécialisée approfondie. Il crée ainsi un modèle de croissance plus reproductible, permettant une exé...

COURBEVOIE, France--(BUSINESS WIRE)--Bureau Veritas (BOURSE:BVI): The execution of LEAP | 28 has transformed Bureau Veritas into a more focused, faster-growing and higher-performing multi-specialist company. Its Product Line-centric operating model combines the Company’s global scale and resilience with clear priorities, stronger accountability and deep specialist expertise. This creates a more repeatable growth model, enabling faster execution, stronger capabilities and higher conversion of gr...

CHENNAI, India--(BUSINESS WIRE)--Vultr, the world’s largest privately-held cloud infrastructure company, today announced a major expansion of its AMD powered infrastructure for enterprise and sovereign cloud initiatives. Vultr will deploy AMD Instinct™ MI355X GPUs in a new 20 MW supercluster in Chennai, India, creating the country’s largest AMD Instinct deployment and giving Vultr two of the world’s largest AMD AI infrastructure deployments globally, alongside its flagship supercluster in Sprin...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Eurofins delivered steady improvement in both organic and reported revenue growth throughout the first nine months of 2026: Reported revenues in 9M 2026 totalled €5,614m, a 3.7% increase versus 9M 2025. Growth was driven by both organic growth13 and acquisitions, despite a -1.7% headwind from foreign exchange, and a -0.7% headwind from discontinuations and disposals15 as Eurofins exited certain non-core activities. Organic reve...

TOKYO--(BUSINESS WIRE)--Beluuga AI, Inc., developer of the beluuga.ai platform, today launched Beluuga Research, an English-language equity research service. It covers 20 Japanese companies now and plans 100% small- and mid-cap coverage within months. Japan has nearly 3,900 listed companies, yet over 70% of TOPIX Small Index stocks have no analyst coverage, and English research is even more scarce. Because research is costly and brokers have little incentive to cover thinly traded stocks, many...

MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma to participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) will showcase data from its leading innovative Injectable Aesthetics portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) taking place in Dubai, United Arab Emirates (UAE), from October 21-23, 2026. The company will present eight scientific abstracts, alongside a symposium and six Meet-the-Expert sessions, all highlighting the expanding benefits of Relfydess, Sculptra, and the Restylane range.1-8 Together, the data de...

Marseille--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société »), une société de biotechnologies au stade clinique qui développe des traitements d’immunothérapies contre le cancer, annonce aujourd’hui que des membres de son équipe de direction participeront aux conférences investisseurs suivantes : Stifel Healthcare Conference Dates : du 10 au 12 novembre 2026 Lieu : New York, États-Unis Présentation « fireside chat » : Date : 1...

ZURICH--(BUSINESS WIRE)--Artificial intelligence has emerged as the most critical challenge facing CEOs worldwide, ahead of geopolitical instability and economic uncertainty, according to The CEO Response, Egon Zehnder's third annual study of 843 global chief executives. Nearly half of CEOs (48%) consider the adoption and impact of AI an extremely critical challenge, up from 37% in 2025. Geopolitical instability (44%) and economic uncertainty (40%) follow, while 62% expect geopolitical disrupti...

PALO ALTO, Kalifornien--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, gab heute bekannt, dass das Unternehmen und seine Forschungspartner auf dem Kongress 2026 der European Society for Medical Oncology (ESMO), der vom 23. bis 27. Oktober in Madrid, Spanien, stattfindet, 25 Abstracts vorstellen werden — darunter fünf „Rapid Oral Presentations“ (kurze mündliche Präsentationen), die Fortschritte bei der methylierungsbasierten Übe...